In this example, the authors have shown that a combination of 6 polymorphisms in neurotransmitter-receptor-related genes resulted in 76.7% success in the prediction of clozapine response.

Investigators have unveiled for the first time that changes in certain genes affect an aggressive cancer, T-cell acute ...

One example is the treatment of tongue cancer with RET inhibitors [1]; here, knowledge of the genetic defects that are present in the cancer allowed drugs to be selected on the basis of their ...

For example, the Clinical Pharmacogenomics Implementation Consortium (CPIC) guidelines 1 were last updated in January 2024, which can be an issue for manufacturers who have already submitted their ...

Two biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease ...

Latest data shows 6,700 more mental health workers have been recruited towards government's 8,500 target. More than 6,700 extra mental health workers ...

Phung: In the medical community, there has been a growing interest and focus on pharmacogenomics ... are most effective for treating conditions common in these groups. For example, my grandma is of ...

Discover how personalized medicine uses genetics and data to create tailored treatments, improving outcomes in cancer, rare diseases, and more. Explore its future in healthcare.

Learn how precision medicine leverages genetics, AI, and big data to deliver personalized healthcare, transforming treatments and outcomes.

If pharmacogenomics testing was performed, the clinical pharmacists reviewed the results and provided recommendations using relevant literature and Clinical Pharmacogenetics Implementation Consortium ...

Pharmacogenomics (PGx) – the study of how genes influence individual responses to drugs – has not been routinely used in clinical practice in the UK, amid hopes evidence will lead to change.